Annual report pursuant to Section 13 and 15(d)

Restatement of Previously issued Financial Statements - Summary Of Effect Of Restatement On Financial Statement (Detail)

v3.21.1
Restatement of Previously issued Financial Statements - Summary Of Effect Of Restatement On Financial Statement (Detail) - USD ($)
5 Months Ended
Dec. 31, 2020
Nov. 27, 2020
Nov. 26, 2020
Jul. 28, 2020
Balance Sheet at :        
Warrant liability $ 36,549,753   $ 36,549,753  
Total liabilities 42,409,421      
Additional paid-in capital 17,260,671      
Accumulated deficit (12,261,549)      
Total shareholders' equity 5,000,006     $ 0
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020        
Excess of fair value of Private Placement Warrants (11,211,642)      
Transaction costs 1,021,001      
Total other income/(expense) (12,221,892)      
Net loss (12,261,549)      
Cash Flows from Operating Activities:        
Net loss (12,261,549)      
Excess value of underwriter warrants 11,211,642      
Net cash used in operating activities (97,168)      
Supplemental disclosure of cash flow information:        
Class A ordinary shares subject to possible redemption (21,295)      
Initial classification of warrant liability 36,549,753      
As Previously Reported [Member]        
Balance Sheet at :        
Total liabilities 5,859,668 $ 5,680,163    
Class A ordinary shares subject to possible redemption 156,864,332 156,885,627    
Class A ordinary shares 93 92    
Additional paid-in capital 5,028,387 5,007,093    
Accumulated deficit (28,906) (7,611)    
Total shareholders' equity 5,000,005 5,000,005    
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020        
Total other income/(expense) 10,751      
Net loss $ (28,906)      
Basic and diluted net loss per share, Class B Ordinary shares $ 0.00      
Cash Flows from Operating Activities:        
Net loss $ (28,906)      
Supplemental disclosure of cash flow information:        
Class A ordinary shares subject to possible redemption 156,864,332      
Adjustment [Member]        
Balance Sheet at :        
Warrant liability 36,549,753 36,549,753    
Total liabilities 36,549,753 36,549,753    
Class A ordinary shares subject to possible redemption (36,549,754) (36,549,754)    
Class A ordinary shares 360 360    
Additional paid-in capital 12,232,284 12,232,284    
Accumulated deficit (12,232,643) (12,232,643)    
Total shareholders' equity 1 1    
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020        
Excess of fair value of Private Placement Warrants (11,211,642)      
Transaction costs (1,021,001)      
Total other income/(expense) (12,232,643)      
Net loss $ (12,232,643)      
Basic and diluted net loss per share, Class B Ordinary shares $ (3.20)      
Cash Flows from Operating Activities:        
Net loss $ (12,232,643)      
Excess value of underwriter warrants 11,211,642      
Transaction costs 1,021,001      
Supplemental disclosure of cash flow information:        
Class A ordinary shares subject to possible redemption (36,549,754)      
Initial classification of warrant liability 36,549,753      
As restated [Member]        
Balance Sheet at :        
Warrant liability 36,549,753 36,549,753    
Total liabilities 42,409,421 42,229,916    
Class A ordinary shares subject to possible redemption 120,314,578 120,335,873    
Class A ordinary shares 453 442    
Additional paid-in capital 17,260,671 17,239,377    
Accumulated deficit (12,261,549) (12,240,254)    
Total shareholders' equity 5,000,006 $ 5,000,006    
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020        
Excess of fair value of Private Placement Warrants (11,211,642)      
Transaction costs (1,021,001)      
Total other income/(expense) (12,221,892)      
Net loss $ (12,261,549)      
Basic and diluted net loss per share, Class B Ordinary shares $ (3.20)      
Cash Flows from Operating Activities:        
Net loss $ (12,261,549)      
Excess value of underwriter warrants 11,211,642      
Transaction costs 1,021,001      
Net cash used in operating activities (97,168)      
Supplemental disclosure of cash flow information:        
Class A ordinary shares subject to possible redemption 120,314,578      
Initial classification of warrant liability $ 36,549,753